Hostname: page-component-7bb8b95d7b-w7rtg Total loading time: 0 Render date: 2024-09-12T20:50:30.143Z Has data issue: false hasContentIssue false
  • English
  • Français

The Effects of Pacatal on Chronic Mental Illness

Published online by Cambridge University Press:  08 February 2018

R. W. Simpson
R. W. Simpson*
Affiliation:
Knowle Hospital, Fareham
Get access Rights & Permissions [Opens in a new window]

Extract

Pacatal is one of the newer so-called tranquillizing drugs. It is a synthetic phenothiazine derivative—N-methyl-piperidyl-(3)-methylphenothiazine which was first investigated in Germany in 1954. It has the same basic structure as chlorpromazine but a different side chain.

Type
Original Articles
Information
Journal of Mental Science , Volume 103 , Issue 432 , July 1957 , pp. 610 - 613
Copyright
Copyright © Royal College of Psychiatrists, 1957 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Bowes, Angus, “The Ataractic Drugs. The Present Position of Chlorpromazine, Frenquel, Pacatal and Reserpine in the Psychiatric Hospital”, Amer. J. Psychiat., 1956, 113, 530.CrossRefGoogle Scholar
2 Gore, C. P., and Biezanek, A., “Agranulocytosis During Treatment with Pacatal”, Lancet, 1956, ii, 1081.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.